MedTrace Logo

Rotator Cuff Reconstruction With Xenologous Dermis-patch Augmentation and ACP® - Injection

NCT01586351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-04-22

No results posted yet for this study

Summary

The purpose of this study is to show that an augmentation with the DX Reinforcement Matrix from Arthrex is possible with the arthroscopic technique.

Conditions

  • Rotator Cuff Tears

Interventions

DEVICE

Patch Augmentation and ACP injection

Patch augmentation and 4mL autologous conditioned plasma application under the footprint following an arthroscopic repair of the rotator cuff.

Sponsors & Collaborators

  • Arthrex, Inc.

    collaborator INDUSTRY

  • Schulthess Klinik

    lead OTHER

Principal Investigators

  • Matthias Flury, Dr · Upper Extremities Department

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-02-28
Completion
2016-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01586351 on ClinicalTrials.gov